New 3M Unit to Develop Tests for Hospital-Acquired Infections
3M Health Care announced yesterday it has launched a new Medical Diagnostics business unit that will focus on rapid diagnostic product solutions that detect key infectious pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and other treatment-resistant microbes.
"3M Medical Diagnostics is a natural extension of our infection prevention platform and enables us to offer hospitals a full spectrum of products that detect, prevent, and treat infections in the hospital setting," said Angela Dillow, Ph.D., global business manager of 3M Medical Diagnostics. "We see many market trends pointing to the need for rapid, easy-to-use microbial diagnostics that will aid in the prevention and control of infections in hospitals in the U.S. and abroad."
The company said it expects to offer rapid diagnostic tests in 2007 that "will allow physicians to make informed medical decisions on behalf of their patients while hospital labs will be able to reduce the amount of hands-on time conducting these tests, which may lead to reduced healthcare costs and improved laboratory profitability." 3M Health Care is one of 3M's six major business segments.